BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20351870)

  • 1. Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays.
    Kawamoto K; Orlando LA; Voora D; Lobach DF; Joy S; Cho A; Ginsburg GS
    AMIA Annu Symp Proc; 2009 Nov; 2009():307-11. PubMed ID: 20351870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PharmGKB: the Pharmacogenetics Knowledge Base.
    Hewett M; Oliver DE; Rubin DL; Easton KL; Stuart JM; Altman RB; Klein TE
    Nucleic Acids Res; 2002 Jan; 30(1):163-5. PubMed ID: 11752281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
    Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
    Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
    McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
    Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence.
    Dorado P; M Peñas-Lledó E
    Pharmacogenomics; 2024 Jan; 25(2):55-58. PubMed ID: 38230665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
    Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
    Buyko E; Beisswanger E; Hahn U
    Pac Symp Biocomput; 2012; ():376-87. PubMed ID: 22174293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enabling the curation of your pharmacogenetic study.
    McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A resource to acquire and summarize pharmacogenetics knowledge in the literature.
    Rubin DL; Carrillo M; Woon M; Conroy J; Klein TE; Altman RB
    Stud Health Technol Inform; 2004; 107(Pt 2):793-7. PubMed ID: 15360921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGxMine: Text mining for curation of PharmGKB.
    Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
    Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
    Lu M; Lewis CM; Traylor M
    BMC Med Genomics; 2017 Jun; 10(1):47. PubMed ID: 28629370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.